Residential REIT's

Post Properties Inc. (PPS), a leading operator and developer of multifamily properties across the U.S., has recently announced a new stock and note repurchase program that would replace its existing share repurchase program in place till the end of 2010. Under the terms of the new program, Post...

Post Properties, Inc. (NYSE: PPS) today announced that its Board of Directors adopted a new stock and note repurchase program under which Post may repurchase up to an aggregate of $200 million of Post's common stock or preferred stock or its operating partnership's senior unsecured notes from time...

National Semiconductor Corporation (NYSE: NSM) was upgraded by FBR Capital from "market perform" to "outperform." NSM's shares closed at $14.11 yesterday. Shares of National Semiconductor have moved down 6.37% year-to-date. Analysts at Keefe Bruyette upgrade Post Properties Inc (NYSE: PPS) from "...

Analysts at Keefe Bruyette downgrade Equity Lifestyle Properties Inc (NYSE: ELS) from "outperform" to "market perform." The target price for ELS is set to $61.50. ELS' shares gained 0.84% to close at $55.41 yesterday. More Analyst Ratings here

Analysts at Keefe Bruyette upgrade Post Properties Inc (NYSE: PPS) from "market perform" to "outperform." The target price for PPS is set to $43. PPS' shares gained 1.17% to close at $34.52 yesterday. More Analyst Ratings here

Reuters Wall St at session highs NEW YORK (Reuters) – Stock indexes hit session highs Thursday afternoon, with the Dow industrials and Nasdaq Composite up more than 1 percent after the European Central Bank left in place a liquidity safety net for vulnerable banks, and U.S. data gave extra support...

Post Properties, Inc. (NYSE: PPS) today announced quarterly dividends on its common stock of $0.20 per share for the fourth quarter of 2010. The dividend is payable on January 14, 2011 to all common stock shareholders of record as of January 3, 2011.

Analysts at Robert W Baird upgrade Optimer Pharmaceuticals Inc (NASDAQ: OPTR) from "neutral" to "outperform." OPTR's shares closed at $9.47 yesterday. Shares of Optimer Pharmaceuticals have fallen by 15.97% so far this year. Essex Property Trust Inc (NYSE: ESS) was upgraded by Janney Capital from "...

Analysts at Janney Capital downgrade Camden Property Trust (NYSE: CPT) from "buy" to "neutral." The target price for CPT is set to $54. CPT's shares lost 1.22% to close at $51.07 yesterday. More Analyst Ratings here

Analysts at Janney Capital upgrade Essex Property Trust Inc (NYSE: ESS) from "neutral" to "buy." The target price for ESS is set to $125. ESS' shares gained 0.26% to close at $110.84 yesterday. More Analyst Ratings here

The analysts at RBC Capital Markets are changing price targets on the following companies: UDR (NYSE: UDR); from $22 to $24 Seagate Tech (NASDAQ: STX); from $15 to $13 Post Properties (NYSE: PPS); from $32 to $40 Camden Property Trust (NYSE: CPT); from $54 to $59 Beacon Roofing Supply (NASDAQ: BECN...

Pfizer (PFE) and its partner Protalix BioTherapeutics Inc. (PLX) recently announced that they have submitted the Marketing Authorization Application (MAA) for their Gaucher disease candidate in the EU. The companies are seeking marketing approval for Uplyso (taliglucerase alfa) from the European...

Temple-Inland Inc (NYSE: TIN) was downgraded by Goldman Sachs from "buy" to "neutral." TIN's stock closed at $21.59 on Friday. Temple-Inland's 52-week trading range is $15.46-$24.73 Frontline Ltd (NYSE: FRO) was downgraded by Deutsche Bank from "buy" to "hold." FRO's shares closed at $26.05 on...

Pfizer (PFE) and its partner Protalix BioTherapeutics Inc. (PLX) recently announced that they have submitted the Marketing Authorization Application (MAA) for their Gaucher disease candidate in the EU. The companies are seeking marketing approval for Uplyso (taliglucerase alfa) from the European...

We have recently changed our long-term recommendation for BRE Properties (BRE), a leading multifamily real estate investment trust (REIT), from 'Neutral' to 'Outperform' with an anticipation that it would perform well above the broader market. The stock presently has a Zacks #3 Rank, which...